Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma - Nywening, T M; Belt, B A; Cullinan, D R (Gut, 2018)